查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1625246

2030 年胞外體市場預測：按產品、來源、技術、最終用戶和地區進行的全球分析

Exosomes Market Forecasts to 2030 - Global Analysis By Product (Exosome Isolation Kits, Exosome Detection and Characterization Kits and Other Products), Source, Technique, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球胞外體市場規模為 1.774 億美元，預計 2030 年將達到 8.8431 億美元，預測期內複合年成長率為 30.7%。

胞外體是由各種細胞類型分泌到體液中的小型膜結合細胞外囊泡。它們的直徑通常為 30 至 150 奈米，攜帶蛋白質、脂質和核酸等生物活性分子，並作為細胞間通訊載體。胞外體不僅在癌症、神經退化性疾病和感染疾病等病理狀況中發揮重要作用，而且在免疫反應和組織修復等生理過程中也發揮重要作用。由於其獨特的性能，它在診斷和治療輸送系統中引起了人們的關注，並有望應用於精準醫療。

根據美國癌症協會估計，到2022年終，將有190萬新發癌症病例和609,360人死亡。

將應用擴展到藥物輸送

胞外體具有高生物相容性和低免疫抗原性，可作為標靶藥物傳遞的天然載體。它能夠封裝 RNA、蛋白質和小分子藥物等治療分子，從而增強治療效果。此外，胞外體工程的進步提高了載藥能力和標靶化精度，正在推動其採用。製藥公司擴大投資於基於胞外體的藥物輸送系統，並認知到它們在精準醫療方面的潛力。預計這一趨勢將在未來幾年顯著推動市場成長。

研發成本高

基於胞外體的治療方法和診斷的開發需要在先進技術、臨床試驗和監管核准方面進行大量投資。這些成本往往限制小型企業和新興企業進入市場。此外，較長的開發時間會增加財務風險，令潛在投資者望而卻步。不斷上升的研發成本也導致最終產品的價格上漲，使醫療保健提供者和患者更難獲得這些產品。因此，基於胞外體的創新的整體成長和傳播面臨嚴重的延遲和障礙。

罕見疾病的治療可能性

胞外體作為卓越的天然載體，為幾乎沒有替代療法的疾病和藥物輸送提供了新的解決方案。它跨越血腦障壁等生物屏障的能力增加了效用。此外，胞外體分離和工程的進步正在促進標靶藥物的開發。人們對個人化醫療和孤兒藥開發的興趣日益濃厚，推動了該領域的進一步研究和投資。因此，胞外體市場由於其在罕見疾病治療方面的變革潛力而正在強勁擴張。

智慧財產糾紛

專利糾紛可能會延遲基於胞外體的新治療方法和診斷工具的開發和商業化。捲入訴訟的公司往往面臨訴訟成本增加並轉移研發資源。知識產權糾紛也可能導致市場壟斷、限制競爭、提高價格。由於大公司持有專利保護，小型企業可能難以進入市場。總體而言，此類衝突將減緩基於胞外體的產品和服務的成長和可近性。

COVID-19 的影響

COVID-19大流行胞外體市場產生了正面影響。這場大流行導致了解病毒的研究工作空前激增。胞外體是參與細胞間通訊的囊泡，經過研究可以更了解病毒的感染機制及其對宿主細胞的影響。這增加了對研究 COVID-19 的胞外體相關研究工具和診斷方法的需求。此外，多種 COVID-19 疫苗已被開發並批准用於大流行期間的緊急使用。

預計外泌胞外體分離套件市場在預測期內將是最大的

由於其從各種生物樣本中分離胞外體的有效且可靠的方法，胞外體分離套件盒部分預計將出現良好的成長。這些套件使研究人員能夠提取高品質的胞外體，這對於診斷和治療等下游應用至關重要。隨著對非侵入性診斷的需求增加，這些套件支援液態切片這一主要成長領域的進步。此外，對個人化醫療的日益重視進一步增加了對準確的胞外體分離工具的需求。因此，胞外體分離套件領域透過提高胞外體相關研究和應用的精確度和範圍，為市場擴張做出了重大貢獻。

診斷實驗室產業預計在預測期內複合年成長率最高

透過利用胞外體在非侵入性診斷中的潛力，診斷實驗室領域預計在預測期內將以最高的複合年成長率成長。胞外體含有蛋白質、脂質和核酸等生物標記物，有助於疾病的早期檢測。這些實驗室利用先進技術來分離和分析胞外體，從而能夠準確診斷癌症、神經退化性疾病和心血管疾病。實驗室和生物技術公司之間的合作將促進基於胞外體的創新診斷工具的開發。隨著胞外體應用的認知不斷增強，診斷實驗室在擴大全球胞外體市場方面變得至關重要。

比最大的地區

由於胞外體在診斷、治療和藥物傳遞方面的應用不斷擴大，預計亞太地區將在預測期內佔據最大的市場佔有率。生物技術的進步和對個人化醫療的日益關注是關鍵驅動力。中國、日本和印度等國胞外體研究和商業化方面正在取得快速進展。對非侵入性診斷技術的需求以及癌症和神經退化性疾病等疾病盛行率的上升進一步推動了市場擴張。此外，強大的醫療基礎設施和不斷增加的投資正在增加該地區的市場機會。

複合年成長率最高的地區：

由於生物技術的進步、再生醫學研究的增加以及對個人化治療的需求不斷成長，預計北美在預測期內將表現出最高的複合年成長率。胞外體作為 RNA、蛋白質和脂質的載體，在診斷和藥物傳遞系統中極為重要。該市場受益於癌症治療、神經系統疾病和免疫治療等領域不斷擴大的應用。此外，美國和加拿大研究機構和醫療保健資金的大力支持正在推動創新。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球胞外體市場：依產品

  • 胞外體分離試劑套件
  • 胞外體檢測與表徵試劑套件
  • 胞外體療法
  • 胞外體診斷試劑套件
  • 其他產品

第6章 全球胞外體市場：依來源分類

  • 人源胞外體
  • 動物性胞外體
  • 植物來源胞外體

第7章全球胞外體市場：依技術分類

  • 胞外體分離技術
    • 超速離心
    • 尺寸排阻層析法(SEC)
    • 親和性和捕獲
    • 基於降水的技術
    • 微流體技術
  • 胞外體表徵技術
    • 奈米粒子追蹤分析 (NTA)
    • 電子顯微鏡（EM）
    • 蛋白質印跡法
    • 流式細胞技術
    • 酵素免疫分析法測定法 (ELISA)

第8章全球胞外體市場：依最終用戶分類

  • 製藥和生物製藥公司
  • 學術研究所
  • 診斷實驗室
  • 合約研究組織（CRO）
  • 醫院和診所
  • 其他最終用戶

第9章全球胞外體市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章 公司概況

  • Evox Therapeutics
  • Capricor Therapeutics
  • EXO Biologics
  • Aethlon Medical
  • Coya Therapeutics
  • Aegle Therapeutics Corporation
  • Aragen Bioscience
  • RoosterBio, Inc.
  • Bio-Techne
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • Hologic Inc.
Product Code: SMRC28201

According to Stratistics MRC, the Global Exosomes Market is accounted for $177.4 million in 2024 and is expected to reach $884.31 million by 2030 growing at a CAGR of 30.7% during the forecast period. Exosomes are tiny, membrane-bound extracellular vesicles secreted by various cell types into bodily fluids. Typically 30-150 nanometres in diameter, they carry bioactive molecules such as proteins, lipids, and nucleic acids, serving as intercellular communication vehicles. Exosomes play crucial roles in physiological processes, including immune responses and tissue repair, as well as pathological conditions like cancer, neurodegenerative diseases, and infections. Their unique properties have made them a focus in diagnostics and therapeutic delivery systems, offering potential for precision medicine applications.

According to the American Cancer Society, an estimated 1.9 million new cancer cases and 609,360 cancer deaths were recorded by the end of 2022.

Market Dynamics:

Driver:

Growing applications in drug delivery

Exosomes serve as natural carriers for targeted drug delivery, offering high biocompatibility and low immunogenicity. Their ability to encapsulate therapeutic molecules, such as RNA, proteins, and small drugs, enhances treatment efficacy. Moreover, advancements in engineering exosomes to improve drug-loading capacity and targeting precision have fuelled their adoption. Pharmaceutical companies are increasingly investing in exosome-based drug delivery systems, recognizing their potential for precision medicine. This trend is expected to significantly boost market growth in the coming years.

Restraint:

High cost of research and development

Developing exosome-based therapies and diagnostics requires substantial investment in advanced technologies, clinical trials, and regulatory approvals. These expenses often limit the ability of smaller companies and startups to enter the market. Moreover, the long development timeline increases financial risks, discouraging potential investors. High R&D costs also lead to increased prices for end products, making them less accessible to healthcare providers and patients. Consequently, the overall growth and widespread adoption of exosome-based innovations face considerable delays and obstacles.

Opportunity:

Therapeutic potential in rare diseases

Exosomes act as natural carriers for focused providing novel solutions for diseases, drug delivery with few therapy alternatives. Their capacity to traverse biological barriers, such as the blood-brain barrier, increases their usefulness in treating complex uncommon diseases. Furthermore, advances in exosome isolation and engineering have permitted the development of targeted medicines. Growing interest in personalized medicine and orphan drug development further propels research and investment in this field. Consequently, the exosome market is witnessing robust expansion due to its transformative potential in treating rare diseases.

Threat:

Intellectual property disputes

Patent conflicts can delay the development and commercialization of new exosome-based therapies and diagnostic tools. Companies involved in litigation often face increased legal costs, diverting resources from research and development. IP disputes can also lead to exclusivity in the market, limiting competition and driving up prices. Smaller firms may struggle to enter the market due to patent protections held by larger players. Overall, these disputes slow down the growth and accessibility of exosome-based products and services.

Covid-19 Impact

The COVID-19 pandemic positively impacted the exosomes market. The pandemic prompted an unprecedented surge in research efforts to understand the virus. Exosomes, being small vesicles involved in cell communication, were studied to better understand the virus's mechanisms of infection and its effects on host cells. This led to increased demand for exosome-related research tools and diagnostics for studying COVID-19. Additionally, several COVID-19 vaccines were developed and authorized for emergency use during the pandemic.

The exosome isolation kits segment is expected to be the largest during the forecast period

The exosome isolation kits segment is estimated to have a lucrative growth, due to the efficient and reliable methods for isolating exosomes from various biological samples. These kits enable researchers to extract high-quality exosomes, essential for downstream applications such as diagnostics and therapeutics. With increasing demand for non-invasive diagnostic methods, these kits support liquid biopsy advancements, a key growth area. Moreover, the growing emphasis on personalized medicine further drives the need for precise exosome isolation tools. As a result, the exosome isolation kit segment contributes significantly to market expansion by enhancing the accuracy and scope of exosome-related research and applications.

The diagnostic laboratories segment is expected to have the highest CAGR during the forecast period

The diagnostic laboratories segment is anticipated to witness the highest CAGR growth during the forecast period, by leveraging their potential in non-invasive diagnostics. Exosomes contain biomarkers like proteins, lipids, and nucleic acids that aid in detecting diseases at an early stage. These laboratories utilize advanced technologies to isolate and analyze exosomes, enabling precise diagnosis of cancer, neurodegenerative disorders, and cardiovascular diseases. Collaborations between labs and biotech firms enhance the development of innovative exosome-based diagnostic tools. As awareness of exosome applications grows, diagnostic laboratories are becoming pivotal in expanding the exosomes market globally.

Region with largest share:

Asia Pacific is expected to hold the largest market share during the forecast period due to increased applications of exosomes in diagnostics, therapeutics, and drug delivery. Advances in biotechnology and the growing focus on personalized medicine are key drivers. Countries like China, Japan, and India are witnessing rapid advancements in exosome-based research and commercialization. The demand for non-invasive diagnostic techniques and the rising prevalence of diseases such as cancer and neurodegenerative disorders are further fuelling market expansion. Additionally, the presence of a robust healthcare infrastructure and increasing investments are boosting market opportunities in this region.

Region with highest CAGR:

North America is expected to have the highest CAGR over the forecast period, owing to advancements in biotechnology, increasing research in regenerative medicine, and rising demand for personalized therapies. Exosomes, as carriers of RNA, proteins, and lipids, are crucial in diagnostics and drug delivery systems. The market is benefiting from the expanding applications in cancer treatment, neurological disorders, and immunotherapy. Additionally, robust support from research institutions and healthcare funding in the U.S. and Canada is propelling innovation.

Key players in the market

Some of the key players profiled in the Exosomes Market include Evox Therapeutics, Capricor Therapeutics, EXO Biologics, Aethlon Medical, Coya Therapeutics, Aegle Therapeutics Corporation, Aragen Bioscience, RoosterBio, Inc., Bio-Techne, Thermo Fisher Scientific, Inc., Danaher and Hologic Inc.

Key Developments:

In June 2024, EXO Biologics announced ongoing partnerships with multiple entities in Europe and the US, emphasizing their strategy to license the ExoPulse platform to accelerate drug development. This approach allows EXO Biologics to focus on direct drug development while enabling ExoXpert to support other companies through licensing agreements.

In April 2024, ExoXpert, a subsidiary of EXO Biologics, entered a strategic partnership with Neucore Bio. This collaboration focuses on evaluating advanced exosome loading using ExoXpert's ExoPulse platform to optimize the delivery of proprietary payloads into exosomes.

In July 2023, Evox completed the acquisition of Codiak Biosciences' engEx-AAV(TM) technology platform. This acquisition includes all intellectual property rights associated with the technology, which facilitates the active loading of adeno-associated virus (AAV) into exosomes, thereby improving delivery efficacy and shielding AAVs from neutralizing antibodies

Products Covered:

  • Exosome Isolation Kits
  • Exosome Detection and Characterization Kits
  • Exosome Therapeutics
  • Exosome Diagnostic Kits
  • Other Products

Sources Covered:

  • Human-Derived Exosomes
  • Animal-Derived Exosomes
  • Plant-Derived Exosomes

Techniques Covered:

  • Exosome Isolation Techniques
  • Exosome Characterization Techniques

End Users Covered:

  • Pharmaceutical and Biopharmaceutical Companies
  • Academic and Research Institutes
  • Diagnostic Laboratories
  • Contract Research Organizations (CROs)
  • Hospitals and Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Exosomes Market, By Product

  • 5.1 Introduction
  • 5.2 Exosome Isolation Kits
  • 5.3 Exosome Detection and Characterization Kits
  • 5.4 Exosome Therapeutics
  • 5.5 Exosome Diagnostic Kits
  • 5.6 Other Products

6 Global Exosomes Market, By Source

  • 6.1 Introduction
  • 6.2 Human-Derived Exosomes
  • 6.3 Animal-Derived Exosomes
  • 6.4 Plant-Derived Exosomes

7 Global Exosomes Market, By Technique

  • 7.1 Introduction
  • 7.2 Exosome Isolation Techniques
    • 7.2.1 Ultracentrifugation
    • 7.2.2 Size Exclusion Chromatography (SEC)
    • 7.2.3 Immunoaffinity Capture
    • 7.2.4 Precipitation-Based Techniques
    • 7.2.5 Microfluidic Technology
  • 7.3 Exosome Characterization Techniques
    • 7.3.1 Nanoparticle Tracking Analysis (NTA)
    • 7.3.2 Electron Microscopy (EM)
    • 7.3.3 Western Blotting
    • 7.3.4 Flow Cytometry
    • 7.3.5 Enzyme-Linked Immunosorbent Assay (ELISA)

8 Global Exosomes Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical and Biopharmaceutical Companies
  • 8.3 Academic and Research Institutes
  • 8.4 Diagnostic Laboratories
  • 8.5 Contract Research Organizations (CROs)
  • 8.6 Hospitals and Clinics
  • 8.7 Other End Users

9 Global Exosomes Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Evox Therapeutics
  • 11.2 Capricor Therapeutics
  • 11.3 EXO Biologics
  • 11.4 Aethlon Medical
  • 11.5 Coya Therapeutics
  • 11.6 Aegle Therapeutics Corporation
  • 11.7 Aragen Bioscience
  • 11.8 RoosterBio, Inc.
  • 11.9 Bio-Techne
  • 11.10 Thermo Fisher Scientific, Inc.
  • 11.11 Danaher
  • 11.12 Hologic Inc.

List of Tables

  • Table 1 Global Exosomes Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Exosomes Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Exosomes Market Outlook, By Exosome Isolation Kits (2022-2030) ($MN)
  • Table 4 Global Exosomes Market Outlook, By Exosome Detection and Characterization Kits (2022-2030) ($MN)
  • Table 5 Global Exosomes Market Outlook, By Exosome Therapeutics (2022-2030) ($MN)
  • Table 6 Global Exosomes Market Outlook, By Exosome Diagnostic Kits (2022-2030) ($MN)
  • Table 7 Global Exosomes Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 8 Global Exosomes Market Outlook, By Source (2022-2030) ($MN)
  • Table 9 Global Exosomes Market Outlook, By Human-Derived Exosomes (2022-2030) ($MN)
  • Table 10 Global Exosomes Market Outlook, By Animal-Derived Exosomes (2022-2030) ($MN)
  • Table 11 Global Exosomes Market Outlook, By Plant-Derived Exosomes (2022-2030) ($MN)
  • Table 12 Global Exosomes Market Outlook, By Technique (2022-2030) ($MN)
  • Table 13 Global Exosomes Market Outlook, By Exosome Isolation Techniques (2022-2030) ($MN)
  • Table 14 Global Exosomes Market Outlook, By Ultracentrifugation (2022-2030) ($MN)
  • Table 15 Global Exosomes Market Outlook, By Size Exclusion Chromatography (SEC) (2022-2030) ($MN)
  • Table 16 Global Exosomes Market Outlook, By Immunoaffinity Capture (2022-2030) ($MN)
  • Table 17 Global Exosomes Market Outlook, By Precipitation-Based Techniques (2022-2030) ($MN)
  • Table 18 Global Exosomes Market Outlook, By Microfluidic Technology (2022-2030) ($MN)
  • Table 19 Global Exosomes Market Outlook, By Exosome Characterization Techniques (2022-2030) ($MN)
  • Table 20 Global Exosomes Market Outlook, By Nanoparticle Tracking Analysis (NTA) (2022-2030) ($MN)
  • Table 21 Global Exosomes Market Outlook, By Electron Microscopy (EM) (2022-2030) ($MN)
  • Table 22 Global Exosomes Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 23 Global Exosomes Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 24 Global Exosomes Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2022-2030) ($MN)
  • Table 25 Global Exosomes Market Outlook, By End User (2022-2030) ($MN)
  • Table 26 Global Exosomes Market Outlook, By Pharmaceutical and Biopharmaceutical Companies (2022-2030) ($MN)
  • Table 27 Global Exosomes Market Outlook, By Academic and Research Institutes (2022-2030) ($MN)
  • Table 28 Global Exosomes Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 29 Global Exosomes Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)
  • Table 30 Global Exosomes Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 31 Global Exosomes Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.